申请人:CHUGAI SEIYAKU KABUSHIKI KAISHA
公开号:US20040067964A1
公开(公告)日:2004-04-08
There is provided a compound represented by the general formula (1):
1
wherein Het represents an optional substituted heterocylic group A
1
and A
2
each independently represent —CH═, etc.; A
3
represents —CH
2
—, etc.; R
1
represents a 4-fluorophenyl group, etc.; R
2
represents an alkyl group; n represents 0, 1 or 2, provided that when A
1
and A
2
both are —CH═, A
3
represents —CH
2
— or —SO
2
—, which is an indole derivative or a mono- or diazaindole derivative that has COX-2 inhibitory activity and is useful as a pharmaceutical, such as an anti-inflammatory agent, or addition salts thereof with a pharmaceutically acceptable acid or base, or hydrates thereof.
提供了一种化合物,其通式表示为(1):其中Het代表可选的取代杂环基A1,A2分别独立地表示—CH═等;A3表示—CH2—等;R1表示4-氟苯基等;R2表示烷基;n表示0、1或2,但当A1和A2均为—CH═时,A3表示—CH2—或—SO2—,该化合物是一种吲哚衍生物或单烷基或双烷基吡唑吲哚衍生物,具有COX-2抑制活性,可用作药物,例如抗炎剂,或其与药用可接受酸或碱的加合物,或其水合物。